RSS   Newsletter   Contact   Advertise with us
Post Online Media

ContraVir appoints Thomas H. Adams to board of directors

ContraVirContraVir Pharmaceuticals, a biopharmaceutical company, announced the appointment of Thomas H. Adams to the company's board of directors.
Article continues below

READ MORE ContraVir appoints John Cavan as chief financial officer

Dr. Adams is a seasoned biotechnology veteran who also currently serves as Chairman of the Board for Trovagene, Inc. Dr. Adams is currently a director of Synergy Pharmaceuticals, Inc.

In addition, he served as a director of IRIS International, Inc. since June 2005 and Chief Technology Officer of IRIS from April 2006 until November 2012 when it was acquired by Danaher Corporation.

Dr. Adams served as Chairman and Chief Executive Officer of Leucadia Technologies, a privately held medical-device company, from 1998 to April 2006, when Leucadia was acquired by IRIS.

Previously, in 1989, he founded Genta, Inc., a publicly held biotechnology company in the field of antisense technology, and served as its Chief Executive Officer until 1997.

Dr. Adams founded Gen-Probe, Inc. in 1984 and served as its Chief Executive Officer and Chairman until its acquisition by Chugai Biopharmaceuticals, Inc. in 1989.

He has significant public company experience serving as a director of Biosite Diagnostics, Inc. from 1989 to 1998 and as a director of Invitrogen from 2000 to 2002.

He holds a Ph.D. in Biochemistry from the University of California, at Riverside.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy